While current research suggests YTHDC2 as a potential tumor biomarker aiding in diagnosis, prognostic evaluation, and treatment selection, further studies are essential to elucidate its mechanisms and clinical applications fully. The gene discussed is YTHDC2; the disease is neoplasm.